In this study, we postulated that RvD1 could inhibit COMP secretion in CAFs in a paracrine manner via FPR2/ROS/FOXM1 signaling to block stoma-tumor cells interactions and then suppress EMT and cancer stemness to alleviate malignant progression of HCC. Here, COMP is linked to neoplasm.